Increased hypertension risk with sorafenib

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1623, 2008-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Felodipine/sorafenib: Sorafenib-induced hypertension, and increased drug toxicity with anorexia due to an interaction (first report) in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Sorafenib

By Rini Brian I

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 453-461

Informa Healthcare

Access to resources Recommend Favorite

Sorafenib/ciclosporin/tacrolimus interaction: Hypertension and gastrointestinal toxicity: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1379, 2011-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite

HAART linked to increased systolic hypertension

Inpharma, Vol. 1, Iss. 1496, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Risk of intraocular hypertension with pegaptanib

Reactions Weekly, Vol. 1, Iss. 1424, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite